We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Bacopa Monnieri wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
2 of 2 studies with measurable effects showed benefit.
Top outcomes
Verdict
Mostly mechanism / observational
1 of 1 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (2)
Outcomes where both Aniracetam and Bacopa Monnieri have evidence — compare verdict strength side-by-side.
750-1500mg daily in divided doses
With fat-containing food (improves absorption), Divided into 2-3 doses due to short half-life, With a choline source
Aniracetam powder or capsules
300-450mg daily (standardized to 50% bacosides)
With fatty meal for absorption
Bacognize® or Synapsa® standardized extract
1-2 weeks
30-60 minutes
1-2 hours
Per dose
8-12 weeks
8-12 weeks
First 2 weeks
First week
The treatment of cognitive dysfunction in dementia: a multiple treatments meta-analysis
Psychopharmacology (2018) · Meta analysis · n=44854
The pooled standardized mean difference of the treatment effects on cognitive dysfunction was 0.439 (95% confidence interval 0.374, 0.504).
Clinical efficacy of aniracetam, either as monotherapy or combined with cholinesterase inhibitors, in patients with cognitive impairment: a comparative open study
CNS neuroscience & therapeutics (2012) · Observational · n=276
In patients treated with aniracetam, all studied parameters were adequately maintained at 6 and 12 months, while emotional state was significantly improved at 3 months.
[Clinical study on a randomized, double-blind control of Shenwu gelatin capsule in treatment of mild cognitive impairment]
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica (2007) · Rct · n=166
Shenwu gelatin capsule has certain effects on mild cognitive impairment.
Efficiency of Different Supplements in Alleviating Symptoms of ADHD with or Without the Use of Stimulants: A Systematic Review
Nutrients (2025) · Systematic review
The evidence revealed the potential use of supplements as complementary ADHD treatments under clinical guidance.
Effectiveness of Bacopa Monnieri (Brahmi) in the management of schizophrenia: a systematic review
Nutritional neuroscience (2025) · Systematic review · n=103
Schizophrenia is a psychotic disorder affecting approximately 0.32% of the global population.
Bacopa monnieri: Preclinical and Clinical Evidence of Neuroactive Effects, Safety of Use and the Search for Improved Bioavailability
Nutrients (2025) · Systematic review
Animal studies have shown promising results in reducing symptoms and protecting against neurodegeneration.
Based on limited RCTs (n=166, n=64) and observational studies (n=276) in cognitive impairment populations. Meta-analysis effect size 0.439 suggests moderate benefit. Studies primarily in elderly/dementia patients, not healthy adults. Fat-soluble compound requiring food intake for absorption.
Based on meta-analysis of 437 participants showing improvements in attention, processing speed, and working memory. However, one large RCT (n=101) found no significant between-group differences. Effects may take 8-12 weeks to manifest. Standardized extracts (Bacognize, Synapsa) may have better bioavailability than generic forms.
AI-estimated from published studies. Interpret as directional guidance.
Bacopa Monnieri has a higher evidence score (6/10 vs 4/10) and wins in 2 of 3 categories.
For improve memory & learning, Bacopa Monnieri has a higher relevance score (95 vs 65).
No known interactions between Aniracetam and Bacopa Monnieri have been documented in our database. However, always consult a healthcare provider before combining supplements.